We are live on ! Find out more
PCM

Palouse Capital Management Portfolio holdings

AUM $160M
1-Year Est. Return 36.15%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$225M
AUM Growth
-$3.97M
Cap. Flow
-$575K
Cap. Flow %
-0.26%
Top 10 Hldgs %
28.76%
Holding
102
New
4
Increased
37
Reduced
51
Closed
7

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$4.28M
2
PPL
PPL Corp
PPL
+$3.11M
3
DGX icon
Quest Diagnostics
DGX
+$3.1M
4
WFC icon
Wells Fargo
WFC
+$2.97M
5
COST icon
Costco
COST
+$851K

Sector Composition

Rank Sector Weight
1 Healthcare 23.06%
2 Technology 14.86%
3 Financials 13.76%
4 Consumer Discretionary 8.96%
5 Consumer Staples 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
51
Amazon
AMZN
$2.96T
$1.9M 0.84%
11,560
-200
-2% -$34.5K
PENN icon
52
PENN Entertainment
PENN
$2.71B
$1.84M 0.82%
+25,429
New +$1.87M
EA
53
DELISTED
Electronic Arts
EA
$1.69M 0.75%
11,873
-184
-2% -$25.8K
VLO icon
54
Valero Energy
VLO
$85.9B
$1.63M 0.72%
23,029
-490
-2% -$32.6K
REGN icon
55
Regeneron Pharmaceuticals
REGN
$80.8B
$1.58M 0.7%
2,608
-1,122
-30% -$697K
VMW
56
DELISTED
VMware, Inc
VMW
$1.55M 0.69%
10,447
+1,999
+24% +$303K
NVR icon
57
NVR
NVR
$17B
$1.52M 0.68%
318
-5
-2% -$25.4K
GS icon
58
Goldman Sachs
GS
$303B
$1.43M 0.63%
3,777
-1,475
-28% -$576K
VRTX icon
59
Vertex Pharmaceuticals
VRTX
$126B
$1.4M 0.62%
7,708
-227
-3% -$44.3K
VCIT icon
60
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$1.33M 0.59%
14,111
-924
-6% -$88.2K
VTRS icon
61
Viatris
VTRS
$18.9B
$1.27M 0.56%
93,737
-2,429
-3% -$34.5K
LQD icon
62
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$1.15M 0.51%
8,607
-761
-8% -$103K
BDX icon
63
Becton Dickinson
BDX
$48.2B
$1.07M 0.48%
4,456
-142
-3% -$34.8K
VRP icon
64
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$1.02M 0.45%
38,768
-2,006
-5% -$52.9K
PHM icon
65
Pultegroup
PHM
$25.3B
$984K 0.44%
21,436
-649
-3% -$33.7K
BABA icon
66
Alibaba
BABA
$308B
$909K 0.4%
6,140
-147
-2% -$26.7K
HII icon
67
Huntington Ingalls Industries
HII
$12.8B
$815K 0.36%
4,221
-88
-2% -$17.8K
CNOB icon
68
Center Bancorp
CNOB
$1.78B
$377K 0.17%
12,551
+715
+6% +$19.8K
PWR icon
69
Quanta Services
PWR
$101B
$339K 0.15%
2,975
+186
+7% +$18.6K
SCHX icon
70
Schwab US Large- Cap ETF
SCHX
$74.5B
$328K 0.15%
18,906
-966
-5% -$17.2K
PLAB icon
71
Photronics
PLAB
$1.93B
$319K 0.14%
23,372
+1,534
+7% +$20.8K
PACW
72
DELISTED
PacWest Bancorp
PACW
$316K 0.14%
6,984
+426
+6% +$17.7K
DGII icon
73
Digi International
DGII
$3.1B
$311K 0.14%
14,782
+869
+6% +$18K
FFIC
74
DELISTED
Flushing Financial
FFIC
$308K 0.14%
13,624
+530
+4% +$11.7K
ITGR icon
75
Integer Holdings
ITGR
$4.26B
$295K 0.13%
3,298
+241
+8% +$22.6K

Similar funds

Palouse Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Palouse Capital Management held 102 positions worth $225M, down 1.7% from $229M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Palouse Capital Management's Q3 2021 filing shows 4 new, 37 increased, 51 reduced and 7 closed positions. Its largest new stake was Walgreens Boots Alliance: 69,638 shares worth $3.28M. The largest sale was Cisco, an estimated $4.28M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Palouse Capital Management's largest Q3 2021 buy was Walgreens Boots Alliance: 69,638 shares worth $3.28M.
  • Palouse Capital Management added most to Citigroup in Q3 2021, an estimated $2.74M increase.
  • Palouse Capital Management's biggest Q3 2021 reduction was Costco, cutting an estimated $851K.
  • Palouse Capital Management fully exited Cisco in Q3 2021, selling an estimated $4.28M.
  • Palouse Capital Management's ten largest holdings make up 29% of its $225M portfolio in Q3 2021.
  • Palouse Capital Management opened 4 new positions and closed 7 in Q3 2021.
  • Palouse Capital Management's portfolio value fell 1.7% quarter-over-quarter to $225M.

Based on Palouse Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.